Full-Time

Manufacturing Documentation Specialist

Posted on 3/30/2024

AGC Biologics

AGC Biologics

1,001-5,000 employees

Contract development and manufacturing for biopharmaceuticals

Compensation Overview

$36 - $45

Entry, Junior

Seattle, WA, USA

Category
Bioinformatics
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • BS degree in Biology, Chemistry or other relevant discipline or equivalent work experience
  • 0-2 Years Experience in GMP Environment
Responsibilities
  • Performs independent review of GMP documentation and partners with others for corrections
  • Coordinates with Manufacturing and Quality to complete corrections for API release
  • Reviews executed manufacturing batch records for completeness, compliance, and accuracy
  • Accesses systems including Unicorn, BMRAM, AX, and others to retrieve data for batch record completion
  • Obtains information from logbooks and assists with GMP logbook review
  • Participates in MFG operations meetings and gives updates pertaining to batch record review and deviations
  • Supports additional projects including data gathering, utilizing trackers, scanning records as needed
  • May participate in side projects related to continuous improvement efforts

AGC Biologics specializes in the development and manufacturing of biopharmaceuticals, including therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells. The company provides comprehensive services that cover the entire process from initial development to full-scale production, catering to clients ranging from small biotech firms to large pharmaceutical companies. AGC Biologics operates state-of-the-art facilities across the U.S., Europe, and Asia, ensuring compliance with strict quality regulations. What sets AGC Biologics apart from its competitors is its focus on fast-track project capabilities, particularly for orphan drugs and rare diseases, which require quicker development timelines. The company's goal is to support the biopharmaceutical industry by delivering high-quality products and services that help bring new treatments to market efficiently.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$557.7M

Headquarters

Bothell, Washington

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for mRNA technology boosts AGC Biologics' growth potential.
  • The rise of personalized medicine creates opportunities for specialized manufacturing services.
  • The global cell and gene therapy market is projected to reach $35.4 billion by 2026.

What critics are saying

  • Economic instability in the cell and gene therapy sector poses financial challenges.
  • Restructuring and layoffs in Colorado suggest operational disruptions in U.S. operations.
  • Rapid expansion could strain financial resources if not managed carefully.

What makes AGC Biologics unique

  • AGC Biologics offers end-to-end solutions from development to full-scale manufacturing.
  • The company specializes in fast-track projects for orphan drugs and rare diseases.
  • AGC Biologics has a global reach with facilities in the U.S., Europe, and Asia.

Help us improve and share your feedback! Did you find this helpful?

Company News

PharmaSource
May 16th, 2025
AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapy Programs

AGC Biologics partners with Quell Therapeutics to advance Treg cell therapy programs.

Pharma Focus America
May 6th, 2025
AGC Biologics and Novelty Nobility Collaborate on Cell Line Development for Antibody Drug Candidate

AGC Biologics has entered into a multi-stage collaboration with South Korea-based biotechnology company Novelty Nobility Inc. to support the development of a bispecific antibody drug candidate.

Contract Pharma
Apr 3rd, 2025
AGC Biologics Forms Cell and Gene Technologies Division

AGC Biologics, a CDMO, has formed a new Cell and Gene Technologies Division designed to focus and elevate existing AGC Biologics capabilities.

AGC Pharma Chemicals
Mar 20th, 2025
AGC Pharma Chemicals Awarded for Excellence in Manufacturing at the 2025 CDMO Leadership Awards

Additionally, at the event, AGC Biologics was also honored with the award for "Best Quality Management Systems".

BioSpace
Mar 10th, 2025
AGC Biologics Honored by Customers and Industry Leaders for Excellence in Contract Development and Manufacturing

SEATTLE-(BUSINESS WIRE)-AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the company won two awards from the annual CDMO Leadership awards, sponsored by Outsourced Pharma and Life Science Connect.

INACTIVE